We are live on ! Find out more
SCM

Stonebridge Capital Management Portfolio holdings

AUM $220M
This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$281M
AUM Growth
+$15.4M
Cap. Flow
-$10.5M
Cap. Flow %
-3.73%
Top 10 Hldgs %
36.05%
Holding
145
New
5
Increased
21
Reduced
65
Closed
6

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$902K
2
MRK icon
Merck
MRK
+$720K
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$700K
4
SBRA icon
Sabra Healthcare REIT
SBRA
+$454K
5
BKR icon
Baker Hughes
BKR
+$444K

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$1.62M
2
EVHC
Envision Healthcare Holdings Inc
EVHC
+$1.36M
3
CVX icon
Chevron
CVX
+$1.12M
4
SLB icon
SLB Ltd
SLB
+$623K
5
WSM icon
Williams-Sonoma
WSM
+$578K

Sector Composition

Rank Sector Weight
1 Technology 23.72%
2 Healthcare 17.32%
3 Industrials 14.22%
4 Energy 11.1%
5 Consumer Staples 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDX icon
51
Becton Dickinson
BDX
$45.3B
$1.14M 0.41%
5,151
– –
BKR icon
52
Baker Hughes
BKR
$57.8B
$1.12M 0.4%
30,035
+13,823
+85% +$444K
ABT icon
53
Abbott
ABT
$187B
$1.11M 0.39%
18,826
+373
+2% +$20.7K
KMB icon
54
Kimberly-Clark
KMB
$37.6B
$1.1M 0.39%
9,700
– –
VAR
55
DELISTED
Varian Medical Systems, Inc.
VAR
$1.05M 0.38%
9,724
-615
-6% -$66.1K
AVY icon
56
Avery Dennison
AVY
$12.9B
$944K 0.34%
7,908
– –
RDS.B
57
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$938K 0.33%
12,894
– –
BIIB icon
58
Biogen
BIIB
$29.8B
$919K 0.33%
2,736
-1,738
-39% -$558K
MON
59
DELISTED
Monsanto Co
MON
$919K 0.33%
7,680
– –
AGN
60
DELISTED
Allergan plc
AGN
$824K 0.29%
4,682
+1,613
+53% +$289K
UN
61
DELISTED
Unilever NV New York Registry Shares
UN
$807K 0.29%
14,550
– –
PANW icon
62
Palo Alto Networks
PANW
$262B
$787K 0.28%
30,750
-3,180
-9% -$77.4K
EL icon
63
Estee Lauder
EL
$30.6B
$784K 0.28%
6,100
-1,300
-18% -$156K
DD icon
64
DuPont de Nemours
DD
$19.1B
$753K 0.27%
3,943
– –
IVZ icon
65
Invesco
IVZ
$13.3B
$701K 0.25%
18,525
-3,000
-14% -$109K
SBRA icon
66
Sabra Healthcare REIT
SBRA
$5.63B
$701K 0.25%
39,325
+22,825
+138% +$454K
LLL
67
DELISTED
L3 Technologies, Inc.
LLL
$701K 0.25%
3,348
– –
NSC icon
68
Norfolk Southern
NSC
$77.1B
$686K 0.24%
4,445
– –
REGN icon
69
Regeneron Pharmaceuticals
REGN
$72B
$634K 0.23%
+1,728
New +$700K
NGG icon
70
National Grid
NGG
$81.8B
$631K 0.22%
12,398
-1,294
-9% -$69K
WFC icon
71
Wells Fargo
WFC
$263B
$629K 0.22%
10,051
-1,200
-11% -$67.8K
SJR
72
DELISTED
Shaw Communications Inc.
SJR
$622K 0.22%
28,525
– –
CAG icon
73
Conagra Brands
CAG
$7.37B
$620K 0.22%
16,900
+4,850
+40% +$172K
VRTX icon
74
Vertex Pharmaceuticals
VRTX
$123B
$588K 0.21%
3,722
-225
-6% -$33.3K
BMY icon
75
Bristol-Myers Squibb
BMY
$130B
$558K 0.2%
8,892
-2,500
-22% -$156K
1 2
3
4 5

Similar funds

TLCM
Twin Lakes Capital Management Redwood Shores, California $220M AUM 31.75% 1-Year Est. Return
RM
Radcliff Management New York $220M AUM 22.57% 1-Year Est. Return
DA
DCM Advisors New York $220M AUM 23.37% 1-Year Est. Return
WDC
Woodward Diversified Capital Bakersfield, California $220M AUM 30.39% 1-Year Est. Return
MDCM
Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $220M AUM 18.32% 1-Year Est. Return
LPP
Long Path Partners Stamford, Connecticut $220M AUM 25.96% 1-Year Est. Return
AWM
Aberdeen Wealth Management Lake Bluff, Illinois $219M AUM 16.64% 1-Year Est. Return
TCG
Transcendent Capital Group Edmond, Oklahoma $219M AUM 19.72% 1-Year Est. Return

Stonebridge Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Stonebridge Capital Management held 145 positions worth $281M, up 5.8% from $266M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Stonebridge Capital Management withdrew a net $10.5M in Q4 2017, closing 6 positions and reducing 65 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $1.36M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Stonebridge Capital Management opened a new position in Regeneron Pharmaceuticals worth $634K.

  • Stonebridge Capital Management's largest Q4 2017 buy was Regeneron Pharmaceuticals: 1,728 shares worth $634K.
  • Stonebridge Capital Management added most to Gilead Sciences in Q4 2017, an estimated $902K increase.
  • Stonebridge Capital Management's biggest Q4 2017 reduction was Qualcomm, cutting an estimated $1.62M.
  • Stonebridge Capital Management fully exited Envision Healthcare Holdings Inc in Q4 2017, selling an estimated $1.36M.
  • Stonebridge Capital Management's ten largest holdings make up 36% of its $281M portfolio in Q4 2017.
  • Stonebridge Capital Management opened 5 new positions and closed 6 in Q4 2017.
  • Stonebridge Capital Management's portfolio value rose 5.8% quarter-over-quarter to $281M.

Based on Stonebridge Capital Management's 13F filing for Q4 2017, filed 29 Jan 2018.